Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATAC Bone Density Sub-Protocol
NCT00784940Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jun 1998
- Primary completion
- Mar 2005
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
01
Overview
A Phase 3 trial of anastrozole in breast cancer, sponsored by AstraZeneca. Started Jun 1998; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00784940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784940.